logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

SUN HUNG KAI CO (00086) repurchased 55,000 shares for HK$219,200 on September 23.

date
17:32 23/09/2026
avatar
GMT Eight
Sun Hung Kai & Co. (00086) announced that on September 23, 2026, it repurchased 55,000 shares for HK$219,200, at a repurchase price of HK$3.965-4 per share.
SUN HUNG KAI CO (00086) announced that on September 23, 2026, it repurchased 55,000 shares for HK$219,200, at a repurchase price of HK$3.965-4 per share.
Related Articles
China Stock
Hengdian Group Tospo Lighting (603303.SH) plans to participate in subscribing to Hengdian Bohui Fund shares for no more than 55 million yuan.
HK Stock
MGM CHINA (02282) repurchased 219,200 shares for approximately HK$2.1067 million on September 23.
China Stock
Shanghai RAAS Blood Products (002252.SZ) plans to acquire 100% equity of Boehringer Ingelheim Biopharmaceuticals.
Hengdian Group Tospo Lighting (603303.SH) plans to participate in subscribing to Hengdian Bohui Fund shares for no more than 55 million yuan.
China Stock
MGM CHINA (02282) repurchased 219,200 shares for approximately HK$2.1067 million on September 23.
HK Stock
Shanghai RAAS Blood Products (002252.SZ) plans to acquire 100% equity of Boehringer Ingelheim Biopharmaceuticals.
China Stock
RECOMMEND
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.